Alzey Pharmaceuticals Private Limited

Alzey Pharmaceuticals Private Limited - pharma in Barwala, Haryana, India. FY 2026 financials & compliance.
CIN U51397HR2020PTC089594 Incorporated 23 September 2020 ROC Delhi HQ Barwala, Haryana, India
Active Private Limited Company pharma
Revenue · FY 2025
₹5.56 Cr
▼ 21% YoY
Net loss · FY 2025
₹8.1 Lakh
Net margin -1.5%
EBITDA · FY 2025
₹29.32 Lakh
EBITDA margin 5.3%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹35 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings

About Alzey Pharmaceuticals Private Limited

Data last updated:

Alzey Pharmaceuticals Private Limited is a private limited company based in Barwala, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397HR2020PTC089594. Its GSTIN is 06AAUCA0950C1ZV (Haryana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹35 Lakh. It was formerly known as Alzey Pharmaceutical Private Limited. It is led by directors including Puneet Chaudhry and Preeti Chaudhry.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 202 Industrial Area Phase – 1 Hsiidc Industrial Estate Alipur, Barwala, Haryana, India – 134118.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.56 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹8.1 Lakh (net margin -1.5%) and EBITDA of ₹29.32 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.

As per MCA filings, the company has open charges of ₹1 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.

For more details, the company can be reached via its website alzeypharmaceuticals.com.

Company details

CIN U51397HR2020PTC089594
Registration Number 089594
Incorporation Date 23 September 2020
ROC Delhi
Listing Status Unlisted
Company Status Active

Contact details

Alzey Pharmaceuticals Private Limited's registered office is in Barwala, Haryana. Its website is alzeypharmaceuticals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 202 Industrial Area Phase – 1 Hsiidc Industrial Estate Alipur, Barwala, Haryana, India – 134118
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Alzey Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Alzey Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Alzey Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Alzey Pharmaceuticals Private Limited, buy the company report.

Financials of Alzey Pharmaceuticals Private Limited

FY 2024 filings available

Alzey Pharmaceuticals Private Limited reported revenue of ₹5.56 Cr (down 21% YoY) for FY 2025.

Revenue · FY 2025
₹5.56 Cr ▼ 21%
Net loss · FY 2025
₹8.1 Lakh margin -1.5%
EBITDA · FY 2025
₹29.32 Lakh margin 5.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 6%

Revenue fell 21% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹29.32 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.1 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.3%
Net Profit Margin-1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alzey Pharmaceuticals Private Limited, buy the company report.

Board of directors of Alzey Pharmaceuticals Private Limited

Alzey Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sumeet ChaudhryAdditional Director18 Jan 20215 Years 9 MonthsCurrent
Puneet ChaudhryDirector09 Apr 20224 Years 7 MonthsCurrent
Preeti ChaudhryDirector09 Apr 20224 Years 7 MonthsCurrent

Peer comparison

Alzey Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Element Pharmaceuticals Private Limited₹5.58 Cr (FY 2025)-4.0%Pune, Maharashtra, India
Pleasant Pharmaceuticals Private Limited₹5.58 Cr (FY 2025)0.0%Jaipur, Rajasthan, India
Alzey Pharmaceuticals Private Limitedthis company₹5.56 Cr (FY 2025)-₹8.1 Lakh-1.5%-21.0%Barwala, Haryana, India
Edura Pharmaceuticals Private Limited₹5.55 Cr (FY 2025)-14.0%New Delhi, Delhi, India

To see the full peer comparison of Alzey Pharmaceuticals Private Limited, buy the company report.

Auditor

Alzey Pharmaceuticals Private Limited is audited by KBB & CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
KBB & COFY 2024023819N

Shareholding

The shareholding of Alzey Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Alzey Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Feb 2021100424070Others₹1 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Alzey Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Alzey Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
06AAUCA0950C1ZVHaryanaActive09 Oct 2020

To see the full GST registrations and return filing status of Alzey Pharmaceuticals Private Limited, buy the company report.

Recent activity

Alzey Pharmaceuticals Private Limited has 10 board changes on record since 2021: 5 appointments and 5 cessations. The latest: Chander Mohan ceased to be Director on 10 Jan 2024.

AGM
Alzey Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Alzey Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Chander Mohan ceased to be Director.
Ceased
Swati Bhalla ceased to be Director.
Appointed
Ajay Kumar Soni was appointed as Director.
Ceased
Neeraj Madan ceased to be Director.
Ceased
Prabha Chowdhary ceased to be Director.
Appointed
Preeti Chaudhry was appointed as Director.
Appointed
Puneet Chaudhry was appointed as Director.
Ceased
Sampada Narang ceased to be Director.
Appointed
Sanjeet Kumar was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100424070 was registered on 06 Feb 2021.

2 earlier events are in the company report.

Frequently asked questions

Alzey Pharmaceuticals is an active private limited company based in Barwala, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 September 2020 (6+ years old) and is registered under CIN U51397HR2020PTC089594.

Alzey Pharmaceuticals has 3 current directors:

The latest financial statements of Alzey Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Alzey Pharmaceuticals is 06AAUCA0950C1ZV, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Alzey Pharmaceuticals is U51397HR2020PTC089594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alzey Pharmaceuticals has 2 court cases on record: 2 filed against it.

Alzey Pharmaceuticals was incorporated on 23 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Alzey Pharmaceuticals by revenue are Element Pharmaceuticals Private Limited, Pleasant Pharmaceuticals Private Limited, Edura Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Chander Mohan ceased to be Director on 10 Jan 2024. Swati Bhalla ceased to be Director on 26 Apr 2022. Ajay Kumar Soni was appointed as Director on 09 Apr 2022. Alzey Pharmaceuticals has 10 board changes on record in total.

Alzey Pharmaceuticals can be reached through the website alzeypharmaceuticals.com. Its registered office is in Barwala, Haryana, India.

The registered office of Alzey Pharmaceuticals is at Plot No 202 Industrial Area Phase – 1 Hsiidc Industrial Estate Alipur, Barwala, Haryana, India – 134118.